Carolina Institute for NanoMedicine (CINM) was established in 2010 as an umbrella program to support multidisciplinary nanotechnology research among investigators from variety of backgrounds including College of Arts & Sciences, UNC Eshelman School of Pharmacy, and UNC School of Medicine. The goal of CINM is to improve human health by enhancing the scientific knowledge as well as the transition of basic research discoveries into clinical trials. CINM harbors two centers:
1. The Carolina Center of Cancer Nanotechnology Excellence (C-CCNE)
C-CCNE is an NCI-funded multidisciplinary center. C-CCNE is organized around the central theme of cancer disease control and management through innovative nanotechnologies developed at University of North Carolina at Chapel Hill in order to improve the quality of life and outcomes for cancer patients.
2. The Center for Nanotechnology in Drug Delivery (CNDD)
CNDD was established within the UNC Eshelman School of Pharmacy in 2007. The focus of the CNDD is to safely and effectively translate new drug and imaging discoveries into clinical trials with the goal to improve human health.